IMMUNIC, INC. financial data

Symbol
IMUX on Nasdaq
Location
New York, United States
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 124% % -62%
Debt-to-equity 352% % 714%
Return On Equity -1198% % -516%
Return On Assets -265% % -95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 130,464,825 shares 36%
Common Stock, Shares, Outstanding 90,150,869 shares 0%
Entity Public Float $83,100,000 USD -17%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 155,688,030 shares 55%
Weighted Average Number of Shares Outstanding, Diluted 155,688,030 shares 55%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $81,983,000 USD 2.4%
General and Administrative Expense $21,245,000 USD 18%
Operating Income (Loss) $103,228,000 USD -5.3%
Nonoperating Income (Expense) $6,056,000 USD 783%
Net Income (Loss) Attributable to Parent $97,172,000 USD 3.3%
Earnings Per Share, Basic -0.62 USD/shares 38%
Earnings Per Share, Diluted -0.62 USD/shares 38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $15,483,000 USD -57%
Other Assets, Current $1,200,000 USD 8.2%
Assets, Current $22,869,000 USD -42%
Property, Plant and Equipment, Net $608,000 USD 12%
Operating Lease, Right-of-Use Asset $575,000 USD -42%
Assets $24,052,000 USD -41%
Accounts Payable, Current $10,138,000 USD 29%
Accrued Liabilities, Current $18,645,000 USD 44%
Liabilities, Current $30,618,000 USD 38%
Operating Lease, Liability, Noncurrent $107,000 USD -59%
Liabilities $30,725,000 USD 37%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,648,000 USD -37%
Retained Earnings (Accumulated Deficit) $608,571,000 USD -19%
Stockholders' Equity Attributable to Parent $6,673,000 USD -136%
Liabilities and Equity $24,052,000 USD -41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $21,776,000 USD 9.1%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $47,000 USD -52%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 90,150,869 shares 0%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,364,000 USD -142%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,483,000 USD -57%
Deferred Tax Assets, Valuation Allowance $119,873,000 USD 2.4%
Deferred Tax Assets, Gross $119,873,000 USD 2.4%
Operating Lease, Liability $577,000 USD -43%
Depreciation $42,000 USD 24%
Payments to Acquire Property, Plant, and Equipment $47,000 USD 52%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $98,733,000 USD 1.3%
Lessee, Operating Lease, Liability, to be Paid $599,000 USD -43%
Operating Lease, Liability, Current $470,000 USD -36%
Lessee, Operating Lease, Liability, to be Paid, Year Two $87,000 USD -48%
Lessee, Operating Lease, Liability, to be Paid, Year One $428,000 USD -42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $22,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Three $84,000 USD 7.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $0 USD -100%
Additional Paid in Capital $599,241,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $43,000 USD 65%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%